
    
      The first aim of the study is to demonstrate that tranexamic acid help limit blood loss and
      reduces the use of blood products.

      Secondary objectives are to evaluate impact of tranexamic acid on mortality, success of skin
      grafts and occurrence of deep vein thrombosis or myocardial infarction.
    
  